Job Title: Equity Research Associate, Emerging Oncology
Reports to: Sr. Equity Research Analyst
Department: Equity Research
Location: Boston
Salary Range: $110,000-$170,000
This individual will work closely with senior equity research professionals to assist in preparing and executing analyses of therapeutic areas, novel biopharmaceutical products, individual companies, and their securities. The ideal candidate will possess a strong sense of intellectual curiosity, passion for the stock market as well as the ability to be a strong team player in a fast paced, deadline driven environment.
Primary Duties and Responsibilities:
- Collect and analyze data related to therapeutics and various diseases, including scientific papers, clinical data, and prescription trends
- Draft market research surveys and analyze results
- Interview company executives or medical/industry consultants to develop and maintain sources of information in preparation of analyses
- Build, update and maintain financial models
- Formulate investment recommendations based on fundamental analysis, valuation and risk assessment of individual companies
- Write research reports and notes on companies for distribution to the Leerink sales force and institutional clients
- Keep current of market news
- Answer inquiries from firm personnel and external clients
- Support senior equity research professionals by attending events of special interest
Experience and Qualifications Required:
- Excellent written and verbal communication skills
- Ability to search, understand and interpret scientific and medical publications
- Strong quantitative, financial modeling, forecasting and Excel skills
- Prior business education a plus: MBA or CFA, or other formal business training
- Prior science/medical education a plus: PhD, MD, or other formal science/medical training
- Familiarity and knowledge of the biotechnology and pharmaceutical industries including clinical development, regulatory affairs, business development and commercialization
About Leerink Partners, LLC
Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, and derivative capital markets, equity research, and sales and trading capabilities. The firm’s strategic focus on the healthcare industry empowers it to provide unique advice and insights to its clients. The firm is a broker-dealer registered with the United States Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority.
Equal Employment Opportunity
Leerink Partners is an equal opportunity employer and is dedicated to expanding its commitments and investments to create a more diverse, equitable and inclusive company culture and innovation ecosystem. We are strongly committed to the values and policy of equal employment opportunity across our employment practices.
Actual starting base pay will be determined on skills, experience, and other non-discriminatory factors permitted by law. Total compensation may also include variable incentives, bonuses, benefits, and/or other perks, as outlined in any formal offer made.
Top Skills
Leerink Partners Boston, Massachusetts, USA Office
One Federal Street, 37th Floor, Boston, MA, United States, 02110
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories


